These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18727667)

  • 1. Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
    Puri PK; Lountzis NI; Tyler W; Ferringer T
    J Cutan Pathol; 2008 Dec; 35(12):1134-7. PubMed ID: 18727667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycholoroquine-induced hyperpigmentation.
    Mir A; Boyd KP; Meehan SA; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine-induced hyperpigmentation.
    Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ
    J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
    Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
    Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature.
    Kwak D; Grimes PE
    Int J Womens Dermatol; 2020 Sep; 6(4):268-271. PubMed ID: 33015284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine-induced hyperpigmentation.
    Tracy CL; Blakey B; Parker G; Roebuck J
    J Clin Rheumatol; 2013 Aug; 19(5):292. PubMed ID: 23884186
    [No Abstract]   [Full Text] [Related]  

  • 9. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
    Ivo R; Lopes CA; Reis R
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine-induced hyperpigmentation.
    Kasper RS; Flueckiger B; Gobbi S; Lautenschlager S; Borelli S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):158-61. PubMed ID: 24494645
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine-related hyperpigmentation.
    Muller R; Jarrot PA; Kaplanski G
    Rheumatology (Oxford); 2022 Feb; 61(2):873. PubMed ID: 33871581
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine-induced hyperpigmentation of the skin and bull's-eye maculopathy in rheumatic patients: a case report and literature review.
    Peng JP; Yang XY; Luo F; Yuan XM; Xiong H; Ma WK; Yao XM
    Front Immunol; 2024; 15():1383343. PubMed ID: 38660312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
    Amichai B; Gat A; Grunwald MH
    J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation.
    True DG; Bryant LR; Harris MD; Bernert RA
    Arthritis Rheum; 2002 Jun; 46(6):1698. PubMed ID: 12115210
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ; Vermeer MH; Huizinga TW
    Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
    Eljaaly K; Alireza KH; Alshehri S; Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 36():101812. PubMed ID: 32645478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-associated hyperpigmentation of the oral mucosa: report of four cases.
    Tosios KI; Kalogirou EM; Sklavounou A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Mar; 125(3):e54-e66. PubMed ID: 29287748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
    Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
    Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins in rheumatoid arthritis--two birds with one stone?
    Klareskog L; Hamsten A
    Lancet; 2004 Jun; 363(9426):2011-2. PubMed ID: 15207947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.